As the light chain of MHC-I molecule, B2M plays a pivotal role in tumor antigen presentation, with its expression modulated by diverse mechanisms such as genetics, epigenetics, cytokines, and non-coding RNAs. The gene discussed is B2M; the disease is neoplasm.